Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway
Li-Bo Liu1, Hui Xie1, Yi-Xue Xue1
1Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang 110001, PR China; Institute of Pathology and Pathophysiology, China Medical University, Shenyang 110001, PR China.
Abstract:
The present study was performed to examine whether Endothelial-monocyte-activating polypeptide II (EMAP II) could inhibit glioma growth by inducing rat brain glioma C6 cells apoptosis. The results revealed that the EMAP II decreased cell viability of rat C6 glioma cells in a time-dependent manner. Apoptotic proportion was increased gradually after EMAP II. EMAP II induced the decrease in mitochondrial membrane potential and the release of cytochrome c into the cytosol, followed by activation of caspase-9 and caspase-3. Meanwhile, EMAP II-induced apoptosis was accompanied by an increase of reactive oxygen species (ROS). The significant up-regulation in the expressions of Bax and Apaf-1 as well as down-regulation in the expression of Bcl-2 was observed. The time course change of ROS was prior to the changes of above investigated indexes. All of these results strongly suggest that EMAP II could induce rat C6 glioma cells apoptosis via the mitochondrial pathway, and ROS, Bax/Bcl-2 might be involved in this processing.
Insights
Endothelial-monocyte-activating polypeptide II (EMAP II) effectively inhibits rat glioma C6 cell growth by triggering apoptosis. This process involves the mitochondrial pathway, reactive oxygen species (ROS), and the Bax/Bcl-2 protein ratio.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Gliomas are primary brain tumors with limited treatment options.
- Identifying novel therapeutic agents to induce cancer cell apoptosis is crucial.
Purpose of the Study:
- To investigate the anti-glioma effects of Endothelial-monocyte-activating polypeptide II (EMAP II).
- To determine if EMAP II induces apoptosis in rat brain glioma C6 cells.
- To elucidate the molecular mechanisms underlying EMAP II-induced apoptosis.
Main Methods:
- Cell viability assays were performed on rat C6 glioma cells treated with EMAP II.
- Apoptosis was assessed by measuring changes in mitochondrial membrane potential and cytochrome c release.
- Caspase activation, reactive oxygen species (ROS) production, and expression levels of Bax, Apaf-1, and Bcl-2 were analyzed.
Main Results:
- EMAP II significantly reduced C6 glioma cell viability in a time-dependent manner.
- EMAP II treatment led to increased apoptosis, decreased mitochondrial membrane potential, and cytochrome c release.
- EMAP II induced ROS generation and altered the expression of apoptosis-related proteins (Bax, Apaf-1, Bcl-2).
Conclusions:
- EMAP II effectively inhibits glioma C6 cell growth by inducing apoptosis.
- The mitochondrial pathway, involving caspase activation and ROS production, mediates EMAP II-induced apoptosis.
- The Bax/Bcl-2 ratio plays a role in the apoptotic process triggered by EMAP II.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway


